NDRI: Publications

You are currently filtering by: 2016 prostate

Cancer • 2016 • Fitoterapia 111: 66-72. PMID: 27102611.

Suppression of rat and human androgen biosynthetic enzymes by apigenin: Possible use for the treatment of prostate cancer.

Wang X, Wang G, Li X, Liu J, Hong T, Zhu Q, Huang P, Ge RH

Full Article

• 2016 • The Prostate 76(6): 552-64. PMID: 26732992.

Rapid selection of mesenchymal stem, progenitor cells in primary prostate stromal cultures.

Brennen WN, Kisteman LN, Isaacs JT

Full Article

• 2016 • Oncotarget 7(42): 68650-68661. PMID: 27626681.

Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.

Mathew SO, Chaudhary P, Powers SB, Vishwanatha JK, Mathew PA

Full Article

NDRI is a Not-For-Profit (501c3) Corporation.

CAP Accredited